Abzena, Recognized

Abzena Recognized as a Market-Leading Antibody-Drug Conjugate CDMO in Frost & Sullivan Radar Report

Veröffentlicht: 17.03.2026 um 21:15 Uhr, prnewswire.co.uk

Abzena United States of America California

View original content:https://www.prnewswire.co.uk/news-releases/abzena-recognized-as-a-market-leading-antibody-drug-conjugate-cdmo-in-frost--sullivan-radar-report-302715863.html

en | boerse | 68741552 |